(19)
(11) EP 4 824 069 A1

(12)

(43) Date of publication:
21.10.2026 Bulletin 2026/43

(21) Application number: 24821066.8

(22) Date of filing: 09.12.2024
(51) International Patent Classification (IPC): 
C07D 491/20(2006.01)
C07D 471/20(2006.01)
A61P 27/02(2006.01)
A61K 31/438(2006.01)
C07D 471/10(2006.01)
A61P 25/28(2006.01)
A61P 29/00(2006.01)
(52) Cooperative Patent Classification (CPC):
C07D 491/20; C07D 471/10; C07D 471/20; A61P 27/02; A61P 29/00; A61P 25/28
(86) International application number:
PCT/EP2024/085228
(87) International publication number:
WO 2025/125135 (19.06.2025 Gazette 2025/25)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 11.12.2023 EP 23215459

(71) Applicant: F. Hoffmann-La Roche AG
4070 Basel (CH)

(72) Inventors:
  • ANTOINE, Mathias
    4070 Basel (CH)
  • BARTELS, Bjoern
    4070 Basel (CH)
  • DEY, Fabian
    4070 Basel (CH)
  • EDMONDS, David James
    4070 Basel (CH)
  • HUNZIKER, Daniel
    4070 Basel (CH)
  • KORN, Claudia Irina
    4070 Basel (CH)
  • RAGELLE, Héloïse Alexandra
    4070 Basel (CH)
  • STEINBRECHER, Thomas Bernd
    4070 Basel (CH)
  • URNER, Lorenz Michael
    4070 Basel (CH)
  • VEGA-CES, Sabela
    4070 Basel (CH)

(74) Representative: Neuhaus, Christian Michel 
F. Hoffmann-La Roche AG Grenzacherstrasse 124
4070 Basel
4070 Basel (CH)

   


(54) SPIROPIPERIDINE UREA-DERIVED COMPOUNDS AS SOLUBLE EPOXIDE HYDROLASE INHIBITORS